Bristol-Myers Squibb
Last updated on 2015-01-03T21:55+0300.
About this image
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|---|---|---|
| specialist | 2.44% | EN | 10/10/2017 |
| rival | 26.83% | EN | 16/02/2017 |
| leader | 63.41% | EN | 31/07/2016 |
| chief executive officer | 2.44% | EN | 31/01/2012 |
| rival | 4.88% | PT | 22/03/2006 |
| Names | Lang | Count |
|---|---|---|
| Bristol-Myers Squibb | EN | 61.87% |
| Bristol-Myers Squibb | FR | 9.18% |
| Bristol Myers Squibb | EN | 4.38% |
| Bristol-Myers Squibb | PT | 2.70% |
| Bristol-Myers Squibb | ES | 2.22% |
| Bristol-Myers Squibb | DE | 2.16% |
| Bristol-Myers Squibb | IT | 2.01% |
| Bristol-Myers Squibb | PL | 2.01% |
| Bristol-Myers Squibb | HR | 1.98% |
| Bristol-Myers Squibb | SV | 1.98% |
| Bristol-Myers Squibb | EU | 1.98% |
| Bristol-Myers Squibb | ZH | 1.98% |
| Bristol Myers Squibb | FR | 0.97% |
| Bristol Myers-Squibb | EN | 0.88% |
| Bristol-Meyers Squibb | EN | 0.73% |
| Bristol Myers Squibb | ES | 0.55% |
| Bristol Myers Squibb | RO | 0.52% |
| Bristol-Meyers Squibb | FR | 0.27% |
| Bristol Meyers Squibb | EN | 0.24% |
| Bristol Myers-Squibb | DE | 0.21% |
| Bristol Myers-Squibb | FR | 0.21% |
| Bristol Myers Squibb | PT | 0.21% |
| BRISTOL-MYERS SQUIBB | FR | 0.18% |
| BRISTOL MYERS SQUIBB | FR | 0.12% |
| Bristol-Myers-Squibb | EN | 0.12% |
| Bristol-Myers-Squibb | FR | 0.09% |
| BRISTOL-Myers Squibb | FR | 0.03% |
| Bristol-Myers-Squibb | EU | 0.03% |
| Bristol Meyers Squibb | FR | 0.03% |
| Bristol Myers Squibb | DE | 0.03% |
| Type | Entity Name | Count |
|---|---|---|
 | Inc | 4.73% |
| Novartis | 3.12% |
| Pfizer Inc | 2.62% |
 | Commission | 2.31% |
| Drug Administration | 2.11% |
| Eli Lilly | 2.01% |
| Eisai Co | 1.71% |
| European Union | 1.71% |
| GlaxoSmithKline | 1.31% |
| Novo Nordisk | 1.21% |
| Laura Wood | 1.21% |
| Risk Factors | 1.21% |
| Association | 1.11% |
| Roche Holding AG | 1.11% |
| World Health Organization | 1.01% |
| Wall Street | 0.91% |
| Reuters Group | 0.91% |
| Strategy | 0.91% |
| Astellas Pharma | 0.80% |
| SA | 0.70% |
| Five Forces | 0.70% |
| Annual Meeting | 0.70% |
| Mitsubishi | 0.70% |
| Merck KGaA | 0.60% |
| Celgene Corp | 0.60% |
| Roche Ltd | 0.60% |
| GlaxoSmithKline Plc | 0.60% |
| Boehringer Ingelheim | 0.60% |
| Copyright | 0.60% |
| European Commission | 0.60% |
| Type | Entity Name | Score |
|---|---|---|
| Novartis | 0.0294 |
| Ludmila Danilova | 0.0185 |
| Eli Lilly | 0.0181 |
| Stefania Vallone | 0.0179 |
| Eisai Co | 0.017 |
| Paul Oldfield | 0.0149 |
| Drug Administration | 0.0128 |
| Novo Nordisk | 0.0126 |
| GlaxoSmithKline | 0.0113 |
| Roche Holding AG | 0.0105 |
| Laura Wood | 0.0099 |
| Risk Factors | 0.0095 |
| Astellas Pharma | 0.0082 |
| West Brabant | 0.008 |
| Eric van den Berg | 0.0074 |
| Clare Francis | 0.0067 |
| Five Forces | 0.0066 |
| Annual Meeting | 0.0066 |
| Simon Blagden | 0.0065 |
| David Peacock | 0.0065 |
| Inc | 0.0063 |
| Merck KGaA | 0.0062 |
| Mitsubishi | 0.0061 |
| Celgene Corp | 0.006 |
| GlaxoSmithKline Plc | 0.006 |
| Boehringer Ingelheim | 0.0058 |
| American Society | 0.0058 |
| Abbott Laboratories | 0.0057 |
| Roche Ltd | 0.0056 |
| Strategy | 0.0055 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Thursday, December 8, 2022
3:51:00 PM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 